Compare Moderna, Inc. (MRNA) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Prudential PLC — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Prudential PLC trades at $29.07 (market cap $34.25B). The key difference: Prudential PLC is the larger of the two by market cap, and Prudential PLC pays a 1.88% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PUK | |
|---|---|---|
Market Cap | $23.60B | $34.25B |
Sector | Health | Financials |
52-Week High | $81.80 | $33.61 |
52-Week Low | $22.36 | $24.74 |
Enterprise Value | $19.70B | $35.69B |
Dividend Yield | — | 1.88% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
